Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$11.57 -0.06 | -0.52%
07/06/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 11.63
52 Week High 29.93
52 Week Low 8.86
Avg. Daily Vol. (Mil) 0.70
Beta (3 year) -1.12
Share Related Items
Mkt Cap (Mil) 630.63
Shares Out (Mil) 54.22
Float (Mil) 21.79
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 9.50
Current Ratio 9.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 41.48
Price/Book 1.06
Price/Cash Flow -19.50
Per Share Data
Earnings -1.33
Sales 0.28
Book Value 10.95
Cash Flow -0.60
Business Summary
Tekmira Pharmaceuticals Corp is abiopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
General Information
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
www.tekmira.com
Industry : Drugs
Sector: Health Care
Employees: 103
CEO: Dr. Mark J. Murray,PhD
Short Interest
Current Month (Mil) 4.73
Previous Month (Mil) 4.80
Short Interest Ratio (Days) 6.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -4.20
Return on Investments -5.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter